EdiShorts
UPSC Mains 2015GS Paper 4 (Ethics)QQ11 (Case Study) · 20 marksCase StudyModel answer

Case study: One of the scientists working in the R & D laboratory of a major pharmaceutical company discovers that one of the company’s best selling veterinary…

DirectiveEvaluate
Marks20
Word limit250
PaperGS Paper 4 (Ethics)
What the examiner wants

List the realistic options open to the CEO and weigh the merits and demerits of each before arriving at a reasoned choice.

Common trap: Many answers jump straight to doing it free, ignoring shareholders. The best answers present several options, evaluate each honestly, and show how partnerships and CSR can make a humane choice financially responsible.

SyllabusEthical concerns and dilemmas in government and private institutions; laws, rules, regulations and conscience as sources of ethical guidance; accountability and ethical governance; corporate governance.

The case

One of the scientists working in the R & D laboratory of a major pharmaceutical company discovers that one of the company’s best selling veterinary drugs, B has the potential to cure a currently incurable liver disease that is prevalent in tribal areas. However, developing a variant of the drug suitable for human beings entailed a lot of research and development having a huge expenditure to the extent of ₹ 50 crores. It was unlikely that the company would recover the costs as the disease was rampant only in poverty-stricken area having very little market otherwise. If you were the CEO, then— (a) identify the various actions that you could take; (b) evaluate the pros and cons of each of your actions.

Model answer

20 marks · 250-word limit

The dilemma is between shareholder value and the moral pull of a cure for poor tribal patients. Milton Friedman argued in 1970 that business's social responsibility is to increase profits; stakeholder thinking and Gandhi's idea of trusteeship ask that wealth also serve those who need it most.

Shareholder lens
  • Fiduciary duty to investors
  • Little market, costs unlikely to be recovered
  • Funds diverted from profitable R&D
vs
Stakeholder lens
  • Incurable disease among the poorest
  • Company holds unique knowledge
  • Reputation, trust, long-term licence to operate
Two lenses on the ₹50 crore decision

(a) Actions available to the CEO

  • Shelve the research: Treat it as commercially unviable and continue only the veterinary product.
  • Develop it alone as a social project: Fund the ₹50 crore from internal resources and supply the drug at cost or free.
  • Fund through CSR: Section 135 of the Companies Act 2013, in force since April 2014, requires qualifying companies to spend 2% of average net profit; promoting health care is a Schedule VII activity.
  • Partnerships: Co-develop with ICMR, government health programmes, global health foundations or non-profit drug developers to share cost and risk, with the state buying the drug for tribal areas.
  • Share or license the knowledge: Pass the data and rights to a public or non-profit body if the company cannot carry the project.

(b) Pros and cons of each action

ActionProsCons
ShelveProtects profits; avoids riskAbandons a curable suffering; reputational and moral cost; knowledge wasted
Go it aloneFull control; strong goodwillHeavy burden on shareholders; may hurt other R&D
CSR routeLawful, board-approved use of mandated funds; brand trustCSR budget may be too small; CSR Rules 2014 exclude normal-course-of-business activity, so CSR suits free supply and screening more than core R&D
PartnershipsCost and risk shared; government reach to tribal areasSlower decisions; sharing of rights and credit
License or shareCure still reaches patients; low costLoss of potential future revenue and control

Recommended course

  • Hybrid path: Combine CSR funds with a partnership with ICMR and state governments, with an advance purchase commitment for tribal health programmes.
  • Ethical trials: Follow the Drugs and Cosmetics Act 1940 and ICMR ethical guidelines, with genuine informed consent in local languages, as tribal patients are a vulnerable group.
  • Precedent: In the late 1980s Merck pledged to donate ivermectin, first sold as a veterinary drug, to fight river blindness; its discoverers shared the 2015 Nobel Prize in Medicine.

A company that turns its own discovery into a cure for the forgotten poor earns trust no advertisement can buy. Through CSR, partnerships and fair trials, the CEO can honour both fiduciary duty and conscience, treating tribal patients as ends in themselves, as Kant would demand.

Answer length. This model answer runs to about 387 words so that every relevant angle is covered. In the exam, write to the 250-word limit: keep the opening, the strongest one or two points under each heading, the diagram and the conclusion.

Read more — sources

  • OfficialCompanies Act, 2013 — Section 135 and Schedule VII; Companies (CSR Policy) Rules, 2014
  • OfficialICMR, Ethical Guidelines for Biomedical Research on Human Participants (2006)
  • OfficialDrugs and Cosmetics Act, 1940 and Rules (Schedule Y, clinical trials)
  • BookMilton Friedman, The Social Responsibility of Business Is to Increase Its Profits, New York Times Magazine (1970)

Related questions from earlier years

More from GS Paper 4 (Ethics) 2015

QQ1(a)·10 marks·150 words·Ethics
What is meant by ‘environmental ethics’? Why is it important to study? Discuss any one environmental issue from the viewpoint of environmental ethics.
Environmental ethics is the branch of applied ethics that asks what duties humans owe to nature — other species, ecosystems and future generations — and whether nature…
Read the model answer →
QQ1(b)·10 marks·200 words·Ethics
Differentiate between the following: (i) Law and Ethics (ii) Ethical management and Management of ethics (iii) Discrimination and Preferential treatment (iv) Personal ethics and Professional ethics
Ethics in public life works at several levels — rule and value, individual and institution. The four pairs below look alike but differ in source, scope and sanction.
Read the model answer →
QQ2(a)·10 marks·150 words·Ethics
Given are two quotations of moral thinkers/philosophers. For each of these, bring out what it means to you in the present context: “The weak can never forgive; forgiveness is the attribute of the strong.”
Gandhi made this remark in a press interview in Karachi after the execution of Bhagat Singh, published in Young India on 2 April 1931. Forgiveness, for him, is not…
Read the model answer →
QQ2(b)·10 marks·150 words·Ethics
Given are two quotations of moral thinkers/philosophers. For each of these, bring out what it means to you in the present context: “We can easily forgive a child who is afraid of the dark; the real tragedy of life is when men are afraid of the light.”
This line is popularly attributed to Plato but cannot be found in his writings; its spirit echoes his Allegory of the Cave in the Republic, where prisoners prefer…
Read the model answer →
QQ3(a)·10 marks·150 words·Ethics
“A mere compliance with law is not enough, the public servant also has to have a well-developed sensibility to ethical issues for effective discharge of duties.” Do you agree? Explain with the help of two examples, where (i) an act is ethically right, but…
Law prescribes the minimum standard of conduct; ethics guides the vast area where law is silent, outdated or unjust. The Nolan Committee's Seven Principles of Public…
Read the model answer →

Model answer by the EdiShorts editorial team. It is one well-argued treatment of the question, written to the official word limit — not an official UPSC answer key.